Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,988 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Electrophysiological properties of prion-positive cardiac progenitors derived from murine embryonic stem cells.
Fujii H, Ikeuchi Y, Kurata Y, Ikeda N, Bahrudin U, Li P, Nakayama Y, Endo R, Hasegawa A, Morikawa K, Miake J, Yoshida A, Hidaka K, Morisaki T, Ninomiya H, Shirayoshi Y, Yamamoto K, Hisatome I. Fujii H, et al. Among authors: hasegawa a. Circ J. 2012;76(12):2875-83. doi: 10.1253/circj.cj-12-0126. Epub 2012 Sep 4. Circ J. 2012. PMID: 22972200 Free article.
[Measurement of triglycerides].
Hasegawa A. Hasegawa A. Nihon Rinsho. 2007 Jul 28;65 Suppl 7:164-8. Nihon Rinsho. 2007. PMID: 17824030 Review. Japanese. No abstract available.
Simultaneous treatment with azelnidipine and olmesartan inhibits apoptosis of Hl-1 cardiac myocytes expressing E334k cMyBPC.
Bahrudin U, Ikeda N, Utami SB, Maharani N, Morikawa K, Li P, Sobirin MA, Hasegawa A, Sakata S, Endo R, Rifqi S, Shirayoshi Y, Yamamoto K, Ninomiya H, Hisatome I. Bahrudin U, et al. Among authors: hasegawa a. Drug Res (Stuttg). 2013 Oct;63(10):515-20. doi: 10.1055/s-0033-1347188. Epub 2013 Jun 5. Drug Res (Stuttg). 2013. PMID: 23740383
Diagnostic implications of circulating oxidized low density lipoprotein levels as a biochemical risk marker of coronary artery disease.
Suzuki T, Kohno H, Hasegawa A, Toshima S, Amaki T, Kurabayashi M, Nagai R, Suzuki T, Amaki T, Nagai R, Hasegawa A, Toshima S, Kurabayashi MH, Shimada K, Nakamura H, Teramoto T, Yamaguchi H, Nishiyama S, Takahashi H, Michishita I, Sugano Z, Konoshi K; Clinical Trial of Oxidized LDL (CTOL) investigators. Suzuki T, et al. Among authors: hasegawa a. Clin Biochem. 2002 Jul;35(5):347-53. doi: 10.1016/s0009-9120(02)00326-0. Clin Biochem. 2002. PMID: 12270763
Stabilization of Kv1.5 channel protein by bepridil through its action as a chemical chaperone.
Suzuki S, Kurata Y, Li P, Notsu T, Hasegawa A, Ikeda N, Kato M, Miake J, Sakata S, Shiota G, Yoshida A, Ninomiya H, Higaki K, Yamamoto K, Shirayoshi Y, Hisatome I. Suzuki S, et al. Among authors: hasegawa a. Eur J Pharmacol. 2012 Dec 5;696(1-3):28-34. doi: 10.1016/j.ejphar.2012.09.025. Epub 2012 Sep 28. Eur J Pharmacol. 2012. PMID: 23026372
Uric Acid-Induced Enhancements of Kv1.5 Protein Expression and Channel Activity via the Akt-HSF1-Hsp70 Pathway in HL-1 Atrial Myocytes.
Taufiq F, Maharani N, Li P, Kurata Y, Ikeda N, Kuwabara M, Otani N, Miake J, Hasegawa A, Tsuneto M, Shirayoshi Y, Ninomiya H, Saitoh T, Nakai A, Yamamoto K, Hisatome I. Taufiq F, et al. Among authors: hasegawa a. Circ J. 2019 Mar 25;83(4):718-726. doi: 10.1253/circj.CJ-18-1088. Epub 2019 Feb 20. Circ J. 2019. PMID: 30787218 Free article.
1,988 results